| Nome |
# |
|
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche
[Clinical conditions associated with abnormal QT interval: clinical implications], file e39773b4-9259-35a3-e053-3a05fe0aac26
|
1.813
|
|
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease?, file e39773b4-9a33-35a3-e053-3a05fe0aac26
|
965
|
|
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry, file e39773b7-20c9-35a3-e053-3a05fe0aac26
|
497
|
|
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases, file 2631bf42-252b-450c-ac1b-cf2849b825f4
|
459
|
|
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations, file e39773b4-a3b8-35a3-e053-3a05fe0aac26
|
442
|
|
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management, file 65119922-152f-43ea-9239-e1d9663a4fae
|
266
|
|
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms, file e39773b4-6f0f-35a3-e053-3a05fe0aac26
|
255
|
|
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome, file e39773b7-399a-35a3-e053-3a05fe0aac26
|
242
|
|
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology, file e39773b4-6aef-35a3-e053-3a05fe0aac26
|
219
|
|
Congenital long QT syndrome, file e39773b4-95f8-35a3-e053-3a05fe0aac26
|
217
|
|
The Long QT Syndrome, file e39773b4-9a30-35a3-e053-3a05fe0aac26
|
207
|
|
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation, file e39773b8-43d4-35a3-e053-3a05fe0aac26
|
181
|
|
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy, file e39773b4-9971-35a3-e053-3a05fe0aac26
|
168
|
|
Heritable arrhythmias associated with abnormal function of cardiac potassium channels, file e39773b7-079b-35a3-e053-3a05fe0aac26
|
164
|
|
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome, file e39773b4-99b4-35a3-e053-3a05fe0aac26
|
159
|
|
Worldwide Survey of COVID-19-Associated Arrhythmias, file e39773b8-69f4-35a3-e053-3a05fe0aac26
|
157
|
|
Genetic Mosaicism in Calmodulinopathy, file e39773b6-2d3b-35a3-e053-3a05fe0aac26
|
155
|
|
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome., file e39773b6-2d42-35a3-e053-3a05fe0aac26
|
146
|
|
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1, file e39773b4-6ed8-35a3-e053-3a05fe0aac26
|
143
|
|
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients, file e39773b4-6d50-35a3-e053-3a05fe0aac26
|
141
|
|
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes, file e39773b5-3c55-35a3-e053-3a05fe0aac26
|
141
|
|
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients, file e39773b4-65fc-35a3-e053-3a05fe0aac26
|
137
|
|
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case., file e39773b4-66cd-35a3-e053-3a05fe0aac26
|
135
|
|
Infanticide vs. inherited cardiac arrhythmias., file e39773b7-071b-35a3-e053-3a05fe0aac26
|
135
|
|
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies, file e39773b4-6aa0-35a3-e053-3a05fe0aac26
|
126
|
|
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome, file e39773b7-8611-35a3-e053-3a05fe0aac26
|
121
|
|
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young, file e39773b5-e650-35a3-e053-3a05fe0aac26
|
118
|
|
Indications and utility of cardiac genetic testing in athletes, file 7eea53d6-be5b-458b-87f5-4fbcd8626548
|
117
|
|
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1, file e39773b4-6f99-35a3-e053-3a05fe0aac26
|
116
|
|
The long QT syndrome: from genetic basis to treatment, file e39773b4-99a3-35a3-e053-3a05fe0aac26
|
107
|
|
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations, file e39773b4-a23c-35a3-e053-3a05fe0aac26
|
107
|
|
Ion channels and beating heart: the players and the music, file e39773b4-9d70-35a3-e053-3a05fe0aac26
|
106
|
|
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition, file e39773b6-2b5f-35a3-e053-3a05fe0aac26
|
103
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene, file e39773b6-2d46-35a3-e053-3a05fe0aac26
|
99
|
|
SCN5A mutation type and a genetic risk score associate variably with brugada syndrome phenotype in SCN5A families, file e39773b7-3827-35a3-e053-3a05fe0aac26
|
97
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation, file e39773b5-e5e1-35a3-e053-3a05fe0aac26
|
96
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation, file e39773b6-2d41-35a3-e053-3a05fe0aac26
|
96
|
|
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population, file e39773b6-453e-35a3-e053-3a05fe0aac26
|
96
|
|
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome, file e39773b7-011a-35a3-e053-3a05fe0aac26
|
93
|
|
Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators, file e39773b7-4908-35a3-e053-3a05fe0aac26
|
91
|
|
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes, file e39773b7-06a4-35a3-e053-3a05fe0aac26
|
79
|
|
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease, file e39773b7-4911-35a3-e053-3a05fe0aac26
|
76
|
|
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1, file e39773b5-e5d9-35a3-e053-3a05fe0aac26
|
75
|
|
Can a message from the dead save lives?, file e39773b4-9433-35a3-e053-3a05fe0aac26
|
70
|
|
Adenosine and the Cardiovascular System: The Good and the Bad., file e39773b6-fcab-35a3-e053-3a05fe0aac26
|
67
|
|
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey, file 0eec308f-1a33-44a0-8701-2710f074ee25
|
62
|
|
Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the italian society of cardiology, file e39773b6-2b5e-35a3-e053-3a05fe0aac26
|
59
|
|
Sex-Related Differences in Cardiac Channelopathies: Implications for Clinical Practice, file e39773b8-6456-35a3-e053-3a05fe0aac26
|
52
|
|
COVID-19 pandemia and inherited cardiomyopathies and channelopathies: A short term and long term perspective, file e39773b6-d6e2-35a3-e053-3a05fe0aac26
|
45
|
|
COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias, file e39773b7-20b4-35a3-e053-3a05fe0aac26
|
42
|
|
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19, file 502fdc7b-c4b8-4aa9-ad3b-a2f4ad5aa7dd
|
41
|
|
Multiscale Complexity Analysis of Short QT Interval Variability Series Stratifies the Arrhythmic Risk of Long QT Syndrome Type 1 Patients, file e39773b7-8fc2-35a3-e053-3a05fe0aac26
|
40
|
|
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls, file e39773b6-e6c8-35a3-e053-3a05fe0aac26
|
39
|
|
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases, file 695f118e-a1a1-4b07-81d5-82361aeb819b
|
38
|
|
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features, file e39773b8-8b84-35a3-e053-3a05fe0aac26
|
38
|
|
Congenital Short QT Syndrome, file e39773b4-9405-35a3-e053-3a05fe0aac26
|
27
|
|
Importance of Dedicated Units for the Management of Patients with Inherited Arrhythmia Syndromes, file e39773b8-b27d-35a3-e053-3a05fe0aac26
|
27
|
|
An explainable model of host genetic interactions linked to COVID-19 severity, file e932aa75-aaff-4f28-b67f-95ee8b3b14fa
|
21
|
|
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases, file ec125abf-77f3-4eeb-8192-e7797d5eabc6
|
21
|
|
Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients, file 10062501-2b29-4b10-9cd9-2005650c1dca
|
19
|
|
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity, file f625add6-b5ae-48ee-9fcd-26b3d0d606ff
|
18
|
|
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants, file 2096f510-deca-468b-94a2-727c0b773620
|
14
|
|
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology, file c12fcd6c-d307-4e4f-a1da-a4af01a9ae45
|
13
|
|
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes, file 4608b8a2-6cf6-43fe-b24a-87a94a4223b0
|
12
|
|
Whole-genome sequencing reveals host factors underlying critical COVID-19, file 24351c14-5278-40a7-b295-48c03e2f3696
|
11
|
|
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey, file 45d053a6-00a5-4947-a820-01a432d1a9f6
|
10
|
|
Sequential defects in cardiac lineage commitment and maturation cause hypoplastic left heart syndrome, file b9a888af-8e65-49d2-a8f0-520b7586f9eb
|
8
|
|
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions, file cea10d0d-3f36-4888-b842-edb17d85e9ce
|
8
|
|
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes, file e39773b3-c5c1-35a3-e053-3a05fe0aac26
|
8
|
|
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis, file 18ce8f56-5916-41e6-a633-85fd66e9e24a
|
6
|
|
Gene symbol: KCNQ1. Disease: Long QT syndrome, file e39773b4-a23b-35a3-e053-3a05fe0aac26
|
5
|
|
Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology, file 0f1612f0-e2a2-4167-89e2-e357a68085a2
|
4
|
|
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility, file 9cb1cd36-93f1-446a-8468-7da3c079e698
|
4
|
|
Gene symbol: KCNQ1. Disease: Long QT syndrome, file e39773b4-9e4b-35a3-e053-3a05fe0aac26
|
4
|
|
Gene Symbol: KCNH2 Disease: Long QT syndrome, file e39773b4-a035-35a3-e053-3a05fe0aac26
|
4
|
|
Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022, Pages 169–177]. (International Journal of Cardiology (2022) 364 (169–177), (S016752732200818X), (10.1016/j.ijcard.2022.05.071)), file 12d2c272-a9ae-4d21-8d5a-fa83cac8735d
|
3
|
|
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis], file 954fd7f5-208f-4309-8bdb-a51346032d35
|
3
|
|
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, file cc8d8713-fc12-44dd-a1a9-baa305d51186
|
3
|
|
Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management, file e102748d-3d9e-4216-9c46-e130bcbea805
|
3
|
|
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome, file e39773b4-93c9-35a3-e053-3a05fe0aac26
|
3
|
|
Inherited cardiac arrhythmia syndrome. Role of potassium channels, file e39773b4-9402-35a3-e053-3a05fe0aac26
|
3
|
|
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant, file e39773b4-98e5-35a3-e053-3a05fe0aac26
|
3
|
|
Gene symbol: SCN5A. Disease: Brugada syndrome, file e39773b4-9e47-35a3-e053-3a05fe0aac26
|
3
|
|
Gene symbol: KCNH2. Disease: Long QT syndrome, file e39773b4-a99e-35a3-e053-3a05fe0aac26
|
3
|
|
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model, file e39773b4-cf7d-35a3-e053-3a05fe0aac26
|
3
|
|
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey, file 0ab404cf-fbe3-4f34-9431-9979189b7de6
|
2
|
|
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94]. (International Journal of Cardiology (2022) 357 (88–94), (S0167527322003850), (10.1016/j.ijcard.2022.03.028)), file c7aa8047-9392-4ef8-8767-0540b2692b23
|
2
|
|
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients, file e39773b4-653c-35a3-e053-3a05fe0aac26
|
2
|
|
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study, file e39773b4-6c35-35a3-e053-3a05fe0aac26
|
2
|
|
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome, file e39773b4-8c93-35a3-e053-3a05fe0aac26
|
2
|
|
Gene symbol: KCNQ1. Disease: Long QT syndrome, file e39773b4-9db2-35a3-e053-3a05fe0aac26
|
2
|
|
Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations, file e39773b4-a3bc-35a3-e053-3a05fe0aac26
|
2
|
|
Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations, file e39773b4-ac7d-35a3-e053-3a05fe0aac26
|
2
|
|
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2, file e39773b5-4dd9-35a3-e053-3a05fe0aac26
|
2
|
|
Long and Short QT syndromes., file e39773b5-ebb3-35a3-e053-3a05fe0aac26
|
2
|
|
Long and Short QT Syndromes, file e39773b6-1625-35a3-e053-3a05fe0aac26
|
2
|
|
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy, file e39773b6-162f-35a3-e053-3a05fe0aac26
|
2
|
|
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome, file e39773b7-3475-35a3-e053-3a05fe0aac26
|
2
|
|
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation", file e39773b4-605e-35a3-e053-3a05fe0aac26
|
1
|
|
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes, file e39773b4-606e-35a3-e053-3a05fe0aac26
|
1
|
| Totale |
10.358 |
